.

The case now travels back to the Fifth Circuit federal appeals court, which has set an expedited briefing schedule to give a fuller

 review of Kacsmaryk’s ruling. A three-judge panel from the Fifth

 Circuit will hold a hearing on May 17 and issue another decision

 sometime after. (There is no deadline for the Fifth Circuit to rule.)

The majority of judges on the Fifth Circuit are conservative, but it

 is unknown who the three judges will be. Notably, the three judges

 who will hear that step of the appeal will likely be different from those that issued the appellate order last week. 

The Supreme Court’s Friday order maintains the status quo

around the drug’s regulations until that Fifth Circuit process plays

 out and until the justices have another chance to weigh in on how it handled the case.